(S)-UH-301 antagonizes (R)-8-OH-DPAT-indiiced cardiovascular effects in the rat

This publication has 9 references indexed in Scilit:

• (S)-UH-301, A NOVEL 5-HT1A RECEPTOR ANTAGONIST
  Behavioural Pharmacology, 1992
• Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats
  European Journal of Pharmacology, 1990
• (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist
  Journal of Medicinal Chemistry, 1990
• Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin
  European Journal of Pharmacology, 1990
• CARDIOVASCULAR EFFECTS FROM STIMULATION OF 5‐HYDROXYTRYPTAMINE RECEPTORS
  Fundamental & Clinical Pharmacology, 1989
• Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats
  European Journal of Pharmacology, 1987
• Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological Analysis
  Journal of Cardiovascular Pharmacology, 1987
• Acute administration of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
• 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982